Treatment results with oral Rocaltrol pulse among patients with secondary hyperparathyroidism in hemodialysis ward
Background and Objective: Renal osteodystrophy is one of the most important complications of ESRD (End Stage Renal Disease). Prescription of calcium, low phosphate diet and rocaltrol are essential in these patients. The aim of this study was to determine the prevalence of renal osteodystrophy and se...
Saved in:
Main Authors: | M Malek, M Fakharian Kashani |
---|---|
Format: | article |
Language: | EN FA |
Published: |
Babol University of Medical Sciences
2004
|
Subjects: | |
Online Access: | https://doaj.org/article/4190f83d774a4994ac2cb7f78b78aeb2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetics of evocalcet in secondary hyperparathyroidism patients receiving hemodialysis: first-in-patient clinical trial in Japan
by: Shigematsu T, et al.
Published: (2018) -
Epidemiological study of orthopedic injuries in hemodialysis patients in Taiwan: a fixed cohort survey, 2004–2008
by: Chang NT, et al.
Published: (2013) -
Experience of surgical treatment of secondary hyperparathyroidism
by: E. A. Ilyicheva, et al.
Published: (2016) -
Results of surgical treatment of uremic hyperparathyroidism (analysis 67 observations)
by: E. A. Il'icheva, et al.
Published: (2018) -
Disputable Issues of Etiology and Pathogenesis of Tertiary Hyperparathyroidism
by: G. A. Bersenev, et al.
Published: (2019)